Literature DB >> 22688062

Review of past research and current concepts on the etiology of moyamoya disease.

Kiyohiro Houkin1, Masaki Ito, Taku Sugiyama, Hideo Shichinohe, Naoki Nakayama, Ken Kazumata, Satoshi Kuroda.   

Abstract

Research on moyamoya disease has progressed remarkably in the past several decades. Indeed, many new facts concerning the epidemiology of the disease have been revealed and surgical treatments have been drastically improved. However, despite extensive research, the mechanism of moyamoya disease is still unknown. Consequently, the cardinal treatment of this disease has not yet been developed. For further clarification of its etiology, innovative studies are therefore indispensable. The aim of this paper is to review research on the pathogenesis of moyamoya disease to identify milestones in the direction of its true solution. Many hypotheses of the pathogenesis of moyamoya disease have been proposed in the past half century, including infection (viral and bacterial), autoimmune disorders, proteins abnormality, and gene abnormality. Some of these are now considered to be historical achievements. Others, however, can be still subjected to contemporary research. Currently, several genetic abnormalities are considered to offer the most probable hypothesis. In addition, interesting papers have been presented on the role of the endothelial progenitor cell on the pathogenesis of moyamoya disease. Intuitively, however, it appears that a single theory cannot always explain the pathogenesis of this disease adequately. In other words, the complex mechanism of several factors may comprehensively explain the formation of moyamoya disease. The "double hit hypothesis" is probably the best explanation for the complicated pathology and epidemiology of this disease.

Entities:  

Mesh:

Year:  2012        PMID: 22688062     DOI: 10.2176/nmc.52.267

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  26 in total

Review 1.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

Review 2.  Pathological Circulating Factors in Moyamoya Disease.

Authors:  Yao-Ching Fang; Ling-Fei Wei; Chaur-Jong Hu; Yong-Kwang Tu
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

Review 3.  Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy-case report and review of literature.

Authors:  Shishir Kumar; Shibu V Pillai
Journal:  Childs Nerv Syst       Date:  2019-02-25       Impact factor: 1.532

4.  'Smoke in the air': a rare cerebrovascular cause of neurological signs and symptoms in a young adult.

Authors:  Imtiaz Ismail; Khalid Al-Khafaji; Monica Mutyala; Saurabh Aggarwal; Nawfal Al-Khafaji; Daniela Kovacs; Sandeep Khosla; Rohit Arora
Journal:  J Community Hosp Intern Med Perspect       Date:  2015-06-15

5.  A New Early Finding of Moyamoya-Like Phenomena.

Authors:  Waqas Jehangir; Zorawar Singh; Harsh Bhatt; Hasan F Al-Azzawi; Kebir H Bedran; Eric J Uhrik; Abdalla Yousif; Teena Mathew
Journal:  J Clin Med Res       Date:  2015-06-09

6.  Moyamoya disease-associated protein mysterin/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state.

Authors:  Daisuke Morito; Kouki Nishikawa; Jun Hoseki; Akira Kitamura; Yuri Kotani; Kazumi Kiso; Masataka Kinjo; Yoshinori Fujiyoshi; Kazuhiro Nagata
Journal:  Sci Rep       Date:  2014-03-24       Impact factor: 4.379

Review 7.  Moyamoya disease and syndromes: from genetics to clinical management.

Authors:  Stéphanie Guey; Elisabeth Tournier-Lasserve; Dominique Hervé; Manoelle Kossorotoff
Journal:  Appl Clin Genet       Date:  2015-02-16

8.  Intracranial stenting using a drug-eluting stent for moyamoya disease involving supraclinoid ICA: a case report.

Authors:  Tackeun Kim; O-Ki Kwon; Chang Wan Oh; Jae Seung Bang; Gyojun Hwang; Young-Jin Lee
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-07       Impact factor: 1.742

9.  A case with unusual stroke and fulminant outcome in a Hispanic male.

Authors:  Sarmad Said; Chad J Cooper; Farhanaz Chowdhury; Angelica Nunez; Raphael Quansah; Harry E Davis
Journal:  Am J Case Rep       Date:  2013-10-21

10.  Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.

Authors:  Lorelei D Shoemaker; Michael J Clark; Anil Patwardhan; Gemma Chandratillake; Sarah Garcia; Rong Chen; Alexander A Morgan; Nan Leng; Scott Kirk; Richard Chen; Douglas J Cook; Michael Snyder; Gary K Steinberg
Journal:  G3 (Bethesda)       Date:  2015-11-03       Impact factor: 3.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.